Analysed REPLIMUNE GROUP INC (REPL:NASDAQ) News Sources
Replimune Plans Layoffs After FDA Rejects Cancer Therapy Again. The Stock Craters 64%.
13-04-2026
yahoo.com
FDA issues complete response letter to Replimune’s RP1 for melanoma
13-04-2026
pharmaceutical-technology.com
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
10-04-2026
yahoo.com
What is the current price of REPLIMUNE GROUP INC (REPL:NASDAQ)?
The current price of REPLIMUNE GROUP INC (REPL:NASDAQ) is $1.68.
REPLIMUNE GROUP INC (REPL:NASDAQ) absolute price change since previous trading day?
The absolute price change of REPLIMUNE GROUP INC (REPL:NASDAQ) since the previous trading day is $-3.08.
REPLIMUNE GROUP INC (REPL:NASDAQ) percentage price change since previous trading day?
The percentage price change of REPLIMUNE GROUP INC (REPL:NASDAQ) since the previous trading day is -64.7059%.
What is the most recent average sentiment score for REPLIMUNE GROUP INC (REPL:NASDAQ)?
The most recent average sentiment score for REPLIMUNE GROUP INC (REPL:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for REPLIMUNE GROUP INC (REPL:NASDAQ)?
The most recent sentiment for REPLIMUNE GROUP INC (REPL:NASDAQ) is .
SEC-8K** Filing Available For REPLIMUNE GROUP INC (REPL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.